CH617936A5 - - Google Patents
Download PDFInfo
- Publication number
- CH617936A5 CH617936A5 CH474375A CH474375A CH617936A5 CH 617936 A5 CH617936 A5 CH 617936A5 CH 474375 A CH474375 A CH 474375A CH 474375 A CH474375 A CH 474375A CH 617936 A5 CH617936 A5 CH 617936A5
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- acceptable salts
- pharmacologically acceptable
- compound
- amino group
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 229910021529 ammonia Inorganic materials 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 241001502500 Trichomonadida Species 0.000 claims 2
- 230000000845 anti-microbial effect Effects 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 2
- JKEVZASQQBRITH-UHFFFAOYSA-N 3-(1-methyl-5-nitroimidazol-2-yl)-[1,2,4]triazolo[4,3-b]pyridazine Chemical class C1=C([N+]([O-])=O)N(C)C(C=2N3N=CC=CC3=NN=2)=N1 JKEVZASQQBRITH-UHFFFAOYSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 241000607142 Salmonella Species 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000000320 amidine group Chemical group 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 150000004957 nitroimidazoles Chemical class 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- -1 p-toluenesulfonyl Chemical group 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229920006158 high molecular weight polymer Polymers 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- ZFBVNPIVXPKPAM-UHFFFAOYSA-N n'-[3-(1-methyl-5-nitroimidazol-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]ethanimidamide Chemical compound N12N=C(NC(=N)C)C=CC2=NN=C1C1=NC=C([N+]([O-])=O)N1C ZFBVNPIVXPKPAM-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NDQXKKFRNOPRDW-UHFFFAOYSA-N 1,1,1-triethoxyethane Chemical compound CCOC(C)(OCC)OCC NDQXKKFRNOPRDW-UHFFFAOYSA-N 0.000 description 1
- HRNUWWVFYGWJFK-UHFFFAOYSA-N 3-(1-methyl-5-nitroimidazol-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine Chemical compound C1=C([N+]([O-])=O)N(C)C(C=2N3N=C(N)C=CC3=NN=2)=N1 HRNUWWVFYGWJFK-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2418435A DE2418435A1 (de) | 1974-04-17 | 1974-04-17 | Nitroimidazolyl-triazolo-pyridazine und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH617936A5 true CH617936A5 (xx) | 1980-06-30 |
Family
ID=5913090
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH474375A CH617936A5 (xx) | 1974-04-17 | 1975-04-14 | |
| CH1010479A CH619226A5 (xx) | 1974-04-17 | 1979-11-12 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1010479A CH619226A5 (xx) | 1974-04-17 | 1979-11-12 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US3948912A (xx) |
| JP (1) | JPS50140488A (xx) |
| AR (1) | AR202974A1 (xx) |
| AT (1) | AT341535B (xx) |
| BE (1) | BE827939A (xx) |
| CA (1) | CA1026339A (xx) |
| CH (2) | CH617936A5 (xx) |
| DD (1) | DD120652A5 (xx) |
| DE (1) | DE2418435A1 (xx) |
| DK (1) | DK136822B (xx) |
| ES (1) | ES436605A1 (xx) |
| FI (1) | FI751093A (xx) |
| FR (1) | FR2267782B1 (xx) |
| GB (1) | GB1458325A (xx) |
| HU (1) | HU169492B (xx) |
| IE (1) | IE40992B1 (xx) |
| IL (1) | IL47082A0 (xx) |
| NL (1) | NL7504404A (xx) |
| PL (1) | PL95094B1 (xx) |
| RO (1) | RO66912A (xx) |
| SE (1) | SE7504374L (xx) |
| SU (1) | SU532340A3 (xx) |
| ZA (1) | ZA752349B (xx) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR70309B (xx) * | 1979-10-29 | 1982-09-08 | Dow Chemical Co | |
| JP4817661B2 (ja) * | 2002-12-18 | 2011-11-16 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼインヒビターとしてのトリアゾロピリダジン |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL128809C (xx) * | 1966-06-18 |
-
1974
- 1974-04-17 DE DE2418435A patent/DE2418435A1/de not_active Withdrawn
-
1975
- 1975-03-17 US US05/559,285 patent/US3948912A/en not_active Expired - Lifetime
- 1975-04-02 CA CA223,700A patent/CA1026339A/en not_active Expired
- 1975-04-10 AR AR258319A patent/AR202974A1/es active
- 1975-04-11 SU SU2121917A patent/SU532340A3/ru active
- 1975-04-11 FI FI751093A patent/FI751093A/fi not_active Application Discontinuation
- 1975-04-11 GB GB1503075A patent/GB1458325A/en not_active Expired
- 1975-04-12 RO RO7581975A patent/RO66912A/ro unknown
- 1975-04-14 ZA ZA00752349A patent/ZA752349B/xx unknown
- 1975-04-14 NL NL7504404A patent/NL7504404A/xx not_active Application Discontinuation
- 1975-04-14 CH CH474375A patent/CH617936A5/de not_active IP Right Cessation
- 1975-04-14 IL IL47082A patent/IL47082A0/xx unknown
- 1975-04-15 JP JP50045737A patent/JPS50140488A/ja active Pending
- 1975-04-15 DD DD185463A patent/DD120652A5/xx unknown
- 1975-04-15 ES ES436605A patent/ES436605A1/es not_active Expired
- 1975-04-15 BE BE155409A patent/BE827939A/xx unknown
- 1975-04-15 DK DK161675AA patent/DK136822B/da not_active IP Right Cessation
- 1975-04-16 FR FR7511790A patent/FR2267782B1/fr not_active Expired
- 1975-04-16 IE IE854/75A patent/IE40992B1/xx unknown
- 1975-04-16 HU HUBO1550A patent/HU169492B/hu unknown
- 1975-04-16 PL PL1975179685A patent/PL95094B1/pl unknown
- 1975-04-16 AT AT289475A patent/AT341535B/de not_active IP Right Cessation
- 1975-04-16 SE SE7504374A patent/SE7504374L/xx unknown
-
1979
- 1979-11-12 CH CH1010479A patent/CH619226A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DD120652A5 (xx) | 1976-06-20 |
| IL47082A0 (en) | 1975-06-25 |
| ES436605A1 (es) | 1977-03-01 |
| IE40992L (en) | 1975-10-17 |
| RO66912A (ro) | 1980-12-30 |
| ZA752349B (en) | 1976-04-28 |
| PL95094B1 (xx) | 1977-09-30 |
| FR2267782B1 (xx) | 1978-10-06 |
| JPS50140488A (xx) | 1975-11-11 |
| GB1458325A (en) | 1976-12-15 |
| AT341535B (de) | 1978-02-10 |
| ATA289475A (de) | 1977-06-15 |
| FI751093A (xx) | 1975-10-18 |
| CH619226A5 (xx) | 1980-09-15 |
| CA1026339A (en) | 1978-02-14 |
| FR2267782A1 (xx) | 1975-11-14 |
| DK136822B (da) | 1977-11-28 |
| AU8012775A (en) | 1976-10-21 |
| US3948912A (en) | 1976-04-06 |
| SU532340A3 (ru) | 1976-10-15 |
| IE40992B1 (en) | 1979-09-26 |
| DE2418435A1 (de) | 1975-10-30 |
| BE827939A (fr) | 1975-10-15 |
| NL7504404A (nl) | 1975-10-21 |
| SE7504374L (sv) | 1975-10-20 |
| HU169492B (xx) | 1976-12-28 |
| AR202974A1 (es) | 1975-07-31 |
| DK161675A (da) | 1975-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2305575C2 (xx) | ||
| DE69204662T2 (de) | Poly-4-aminopyrrole-2-carboxamide derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| DE1595876A1 (de) | Verfahren zur Herstellung von Aminomethylderivaten von Rifamycin SV | |
| DE1802162A1 (de) | Neue N-Pyridylmethyliden-homocystein-thiolacton-Verbindung und Verfahren zu ihrer Herstellung | |
| CH617936A5 (xx) | ||
| DE2215999C3 (xx) | ||
| EP0088323A2 (de) | Imidazothiadiazolalkencarbonsäureamide, neue Zwischenprodukte zu ihrer Herstellung, ihre Herstellung und ihre Verwendung in Arzneimitteln | |
| DE2261735A1 (de) | Nitroimidazolyl-triazolo-pyridazine und verfahren zu ihrer herstellung | |
| DE2222834A1 (de) | Nitrofuryl-amidin-derivate und verfahren zur herstellung derselben | |
| DE932675C (de) | Verfahren zur Herstellung von Estern des Penicillins mit eine sekundaere Aminogruppe aufweisenden Alkoholen und von Salzen dieser Ester | |
| DE2254783A1 (de) | Nitroimidazolyl-triazolo-pyridazine und verfahren zu ihrer herstellung | |
| DE2264979B2 (de) | Thiazolo [3.2-a] pyrimidin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| DE2656574A1 (de) | Neue 1,6-naphthyridincarbonsaeurederivate und verfahren zu ihrer herstellung | |
| CH619696A5 (xx) | ||
| DE2202744A1 (de) | Nitrofuryl-triazolo eckige klammer auf 4,3-b eckige klammer zu-pyridazin-amide | |
| DE1670284C3 (de) | Penicilline | |
| DE2144884A1 (de) | Amino-phenazin-5,10-di-n-oxide und verfahren zu deren herstellung | |
| DE951992C (de) | Verfahren zur Herstellung von neuen Hydrazinderivaten | |
| DE2161587A1 (de) | Nitrofuryl-triazolo eckige klammer auf 4,3-b eckige klammer zu pyridazinderivat | |
| AT333286B (de) | Verfahren zur herstellung von neuen 4(1h)-pyrimidinon-verbindungen und deren salzen | |
| AT362359B (de) | Verfahren zur herstellung von neuen 6-aryl-2,3, 6,7-tetrahydro-5h-pyrrolo (1,2-a)imidazolen und von deren saeureadditionssalzen | |
| DE2261692A1 (de) | Nitroimidazolyl-triazolo-pyridazine und verfahren zu ihrer herstellung | |
| AT216145B (de) | Verfahren zur Herstellung von neuen therapeutisch wertvollen Verbindungen | |
| DE2454406A1 (de) | Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
| DE2202745A1 (de) | Nitrofuryl-triazolo eckige klammer auf 4,3-b eckige klammer zu-pyridazin-carbonsaeurederivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |